Detalles de la búsqueda
1.
Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study.
Hepatobiliary Pancreat Dis Int;
23(3): 249-256, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38040524
2.
[Diffuse Hepatoid Adenocarcinoma in the Peritoneal Cavity:Report of One Case].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao;
46(1): 143-146, 2024 Feb.
Artículo
en Zh
| MEDLINE | ID: mdl-38433645
3.
From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification.
Gut;
72(11): 2149-2163, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549980
4.
Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19).
Clin Infect Dis;
76(3): e148-e154, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35870128
5.
Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score.
Hepatobiliary Pancreat Dis Int;
2023 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38199909
6.
Diverse and precision therapies open new horizons for patients with advanced pancreatic ductal adenocarcinoma.
Hepatobiliary Pancreat Dis Int;
21(1): 10-24, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34538570
7.
Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer.
J Enzyme Inhib Med Chem;
36(1): 1563-1572, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34281464
8.
Comparative study of alterations in phospholipid profiles upon liver cancer in humans and mice.
Analyst;
145(20): 6470-6477, 2020 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32856629
9.
Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China.
Cost Eff Resour Alloc;
16: 29, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30087583
10.
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma.
Int J Cancer;
134(2): 342-51, 2014 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23825037
11.
Predicting effect of anti-PD-1/PD-L1 inhibitors therapy for hepatocellular carcinoma by detecting plasma metabolite based on UHPLC-MS.
Front Immunol;
15: 1370771, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38707906
12.
The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma -CLEAP 004 study.
Front Immunol;
15: 1310239, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38711515
13.
T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis.
iScience;
27(1): 108701, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38222108
14.
Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration.
Cell Death Discov;
9(1): 92, 2023 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906597
15.
Pseudolaric acid B triggers cell apoptosis by activating AMPK/JNK/DRP1/mitochondrial fission pathway in hepatocellular carcinoma.
Toxicology;
493: 153556, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244295
16.
Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol.
BMJ Open;
13(9): e076467, 2023 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37723113
17.
Comparison analysis of PD-1/PD-L1 inhibitors plus lenvatinib or gemcitabine/cisplatin as first-line treatment for patients with advanced intrahepatic cholangiocarcinoma.
Front Oncol;
13: 1204486, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37664019
18.
Anti-cancer treatment within two weeks serves as a risk factor for clinical outcomes among cancer patients with COVID-19.
Front Oncol;
13: 1193082, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37675234
19.
Effectiveness of inactivated COVID-19 vaccines against mild disease, pneumonia, and severe disease among persons infected with SARS-CoV-2 Omicron variant: real-world study in Jilin Province, China.
Emerg Microbes Infect;
12(1): 2149935, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36398721
20.
[Retracted] MicroRNA874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting Xlinked inhibitor of apoptosis protein.
Oncol Rep;
47(4)2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137925